{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:04:09Z","timestamp":1740107049828,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00520-022-07106-2","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T09:02:44Z","timestamp":1652259764000},"page":"6937-6946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for biliary stent infections in malignant biliary obstruction secondary to unresectable malignancies"],"prefix":"10.1007","volume":"30","author":[{"given":"S\u00e9bastien","family":"Petit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Puyade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Pichon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Wangermez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Roblot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Isambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-5848","authenticated-orcid":false,"given":"Blandine","family":"Rammaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"issue":"28","key":"7106_CR1","first-page":"9345","volume":"20","author":"BR Boulay","year":"2014","unstructured":"Boulay BR, Parepally M (2014) Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy. World J Gastroenterol 20(28):9345\u20139353","journal-title":"World J Gastroenterol"},{"issue":"2","key":"7106_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.suc.2009.12.004","volume":"90","author":"EJ Kruse","year":"2010","unstructured":"Kruse EJ (2010) Palliation in pancreatic cancer. Surg Clin N Am 90(2):355\u2013364","journal-title":"Surg Clin N Am"},{"issue":"1","key":"7106_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/gastro\/gou072","volume":"3","author":"A Singh","year":"2015","unstructured":"Singh A, Gelrud A, Agarwal B (2015) Biliary strictures: diagnostic considerations and approach. Gastroenterology Report 3(1):22\u201331","journal-title":"Gastroenterology Report"},{"issue":"18","key":"7106_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691\u20131703","journal-title":"N Engl J Med"},{"issue":"19","key":"7106_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817\u20131825","journal-title":"N Engl J Med"},{"key":"7106_CR6","doi-asserted-by":"publisher","unstructured":"Managing malignant biliary obstruction in pancreas cancer: choosing the appropriate strategy. World J Gastroenterol. 2014; 20(28):9345\u20139353. Published online 2014 Jul 28. https:\/\/doi.org\/10.3748\/wjg.v20.i28.9345","DOI":"10.3748\/wjg.v20.i28.9345"},{"issue":"03","key":"7106_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-0031-1291633","volume":"44","author":"J-M Dumonceau","year":"2012","unstructured":"Dumonceau J-M, Tringali A, Blero D, Devi\u00e8re J, Laugiers R, Heresbach D et al (2012) Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 44(03):277\u2013298","journal-title":"Endoscopy"},{"key":"7106_CR8","unstructured":"Consensus d\u2019endoscopie digestive de la soci\u00e9t\u00e9 fran\u00e7aise d\u2019endoscopie digestive 2009. https:\/\/www.sfed.org\/files\/documents_sfed\/files\/recommandations\/Protheses_biliaires_v2.pdf"},{"issue":"7","key":"7106_CR9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4103\/jcrt.JCRT_256_18","volume":"14","author":"H Yu","year":"2018","unstructured":"Yu H, Yuanyuan S, Guo Z, Xing W, Si T, Guo X et al (2018) Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction. J Can Res Ther 14(7):1503","journal-title":"J Can Res Ther"},{"issue":"5","key":"7106_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21037\/cco.2016.10.07","volume":"5","author":"H Yarmohammadi","year":"2016","unstructured":"Yarmohammadi H, Covey AM (2016) Percutaneous biliary interventions and complications in malignant bile duct obstruction. Chin Clin Oncol 5(5):68\u201368","journal-title":"Chin Clin Oncol"},{"key":"7106_CR11","doi-asserted-by":"crossref","unstructured":"Liu F. Percutaneous biliary stent placement in palliation of malignant bile duct obstruction. Gastroenterol Res [Internet]. 2009 [cited 2020 Sep 20]; Available from: http:\/\/www.gastrores.org\/index.php\/Gastrores\/article\/view\/148","DOI":"10.4021\/gr2009.10.1315"},{"issue":"9","key":"7106_CR12","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1245\/s10434-010-1045-9","volume":"17","author":"PC Robson","year":"2010","unstructured":"Robson PC, Heffernan N, Gonen M, Thornton R, Brody LA, Holmes R et al (2010) Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol 17(9):2303\u20132311","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"7106_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1055\/s-2002-32806","volume":"40","author":"M Beissert","year":"2002","unstructured":"Beissert M, Wittenberg G, Sandstede J, Beer M, Tschammler A, Burghardt W et al (2002) Metallic stents and plastic endoprostheses in percutaneous treatment of biliary obstruction. Z Gastroenterol 40(7):503\u2013510","journal-title":"Z Gastroenterol"},{"issue":"1","key":"7106_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033576","volume":"10","author":"J Rees","year":"2020","unstructured":"Rees J, Mytton J, Evison F, Mangat KS, Patel P, Trudgill N (2020) The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study. BMJ Open 10(1):e033576","journal-title":"BMJ Open"},{"issue":"1","key":"7106_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2214\/AJR.09.2474","volume":"194","author":"YL Sol","year":"2010","unstructured":"Sol YL, Kim CW, Jeon UB, Lee NK, Kim S, Kang DH et al (2010) Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. Am J Roentgenol 194(1):261\u2013265","journal-title":"Am J Roentgenol"},{"issue":"2","key":"7106_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.gie.2015.03.1980","volume":"82","author":"T Sawas","year":"2015","unstructured":"Sawas T, Al Halabi S, Parsi MA, Vargo JJ (2015) Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 82(2):256\u2013267.e7","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"7106_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10620-009-0756-x","volume":"55","author":"H Ho","year":"2010","unstructured":"Ho H, Mahajan A, Gosain S, Jain A, Brock A, Rehan ME et al (2010) Management of complications associated with partially covered biliary metal stents. Dig Dis Sci 55(2):516\u2013522","journal-title":"Dig Dis Sci"},{"issue":"2","key":"7106_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0455.2003.00049.x","volume":"44","author":"M Inal","year":"2003","unstructured":"Inal M, AkgUl E, Aksungur E, DemiryUrek H, Yagmur O (2003) Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol 44(2):139\u2013146","journal-title":"Acta Radiol"},{"issue":"5","key":"7106_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.clinre.2012.12.002","volume":"37","author":"W Hong","year":"2013","unstructured":"Hong W, Chen X, Wu W, Zhu Q, Chen X (2013) Metal versus plastic stents for malignant biliary obstruction: an update meta-analysis. Clin Res Hepatol Gastroenterol 37(5):496\u2013500","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"7106_CR20","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10620-010-1550-5","volume":"56","author":"RP Raju","year":"2011","unstructured":"Raju RP, Jaganmohan SR, Ross WA, Davila ML, Javle M, Raju GS et al (2011) Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci 56(5):1557\u20131564","journal-title":"Dig Dis Sci"},{"issue":"1","key":"7106_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12876-017-0662-1","volume":"17","author":"Y Yokota","year":"2017","unstructured":"Yokota Y, Fukasawa M, Takano S, Kadokura M, Shindo H, Takahashi E et al (2017) Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction: a retrospective study. BMC Gastroenterol 17(1):105","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"7106_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/den.12700","volume":"29","author":"D Gao","year":"2017","unstructured":"Gao D, Hu B, Ye X, Wang T, Wu J (2017) Metal versus plastic stents for unresectable gallbladder cancer with hilar duct obstruction. Dig Endosc 29(1):97\u2013103","journal-title":"Dig Endosc"},{"key":"7106_CR23","unstructured":"ERCP-related adverse events: European society of gastrointestinal Endoscopy Guideline https:\/\/www.sfed.org\/files\/files\/recoesgefr_cpreeffetindesir.pdf"},{"issue":"3","key":"7106_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.gie.2011.07.010","volume":"75","author":"MA Anderson","year":"2012","unstructured":"Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V, Ben-Menachem T et al (2012) Complications of ERCP. Gastrointest Endosc 75(3):467\u2013473","journal-title":"Gastrointest Endosc"},{"key":"7106_CR25","doi-asserted-by":"publisher","unstructured":"Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. https:\/\/doi.org\/10.1002\/jhbp.512","DOI":"10.1002\/jhbp.512"},{"key":"7106_CR26","unstructured":"NHSN Patient Safety Component Manual. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf. Accessed 30 Aug 2021"},{"issue":"10","key":"7106_CR27","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.5858\/2005-129-1222-TIBCCA","volume":"129","author":"LG Bekeris","year":"2005","unstructured":"Bekeris LG, Tworek JA, Walsh MK, Valenstein PN (2005) Trends in blood culture contamination: a College of American Pathologists Q-tracks study of 356 institutions. Arch Pathol Lab Med 129(10):1222\u20131225","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"7106_CR28","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021. Crit Care Med 49(11):1974\u20131982","journal-title":"Crit Care Med"},{"issue":"6","key":"7106_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","volume":"11","author":"AE Stuck","year":"1989","unstructured":"Stuck AE, Minder CE, Frey FJ (1989) Risk of infectious complications in patients taking glucocorticosteroids. Clin Infect Dis 11(6):954\u2013963","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7106_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00534-012-0572-0","volume":"20","author":"H Gomi","year":"2013","unstructured":"Gomi H, Solomkin JS, Takada T, Strasberg SM, Pitt HA, Yoshida M et al (2013) TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepato-Biliary-Pancreat Sci 20(1):60\u201370","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"7106_CR31","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Recommandations 2017. 2017; Available at: http:\/\/www.sfm-microbiologie.org\/UserFiles\/files\/casfm\/CASFMV1_0_MARS_2017.pdf. Accessed 27 Mar 2018"},{"issue":"1","key":"7106_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/trf.14994","volume":"59","author":"T Netelenbos","year":"2019","unstructured":"Netelenbos T, Massey E, Wreede LC, Harding K, Hamblin A, Sekhar M et al (2019) The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions. Transfusion 59(1):160\u2013168","journal-title":"Transfusion"},{"issue":"2","key":"7106_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00464-017-5746-z","volume":"32","author":"J Tierney","year":"2018","unstructured":"Tierney J, Bhutiani N, Stamp B, Richey JS, Bahr MH, Vitale GC (2018) Predictive risk factors associated with cholangitis following ERCP. Surg Endosc 32(2):799\u2013804","journal-title":"Surg Endosc"},{"issue":"4","key":"7106_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jvir.2020.12.020","volume":"32","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang X-J, Guan L-J, Li B, Wang L, Li X-G (2021) Proton pump inhibitors increase the risk of early biliary infection after placement of percutaneous transhepatic biliary stents. J Vasc Interv Radiol 32(4):569\u2013575","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"7106_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jvir.2014.11.008","volume":"26","author":"X Huang","year":"2015","unstructured":"Huang X, Shen L, Jin Y, Chen L, Zhou D, Xu G et al (2015) Comparison of uncovered stent placement across versus above the main duodenal papilla for malignant biliary obstruction. J Vasc Interv Radiol 26(3):432\u2013437","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"7106_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.gie.2005.05.015","volume":"63","author":"T Okamoto","year":"2006","unstructured":"Okamoto T, Fujioka S, Yanagisawa S, Yanaga K, Kakutani H, Tajiri H et al (2006) Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc 63(6):792\u2013796","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"7106_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.gie.2008.12.054","volume":"70","author":"SP Misra","year":"2009","unstructured":"Misra SP, Dwivedi M (2009) Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement. Gastrointest Endosc 70(2):317\u2013321","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"7106_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jvir.2014.11.043","volume":"26","author":"J-H Jo","year":"2015","unstructured":"Jo J-H, Park B-H (2015) Suprapapillary versus transpapillary stent placement for malignant biliary obstruction: which is better? J Vasc Interv Radiol 26(4):573\u2013582","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"7106_CR39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/den.13679","volume":"33","author":"T Hamada","year":"2021","unstructured":"Hamada T, Nakai Y, Isayama H, Koike K (2021) Antireflux metal stent for biliary obstruction: any benefits? Dig Endosc 33(3):310\u2013320","journal-title":"Dig Endosc"},{"issue":"11","key":"7106_CR40","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jvir.2010.07.018","volume":"21","author":"AM Venkatesan","year":"2010","unstructured":"Venkatesan AM, Kundu S, Sacks D, Wallace MJ, Wojak JC, Rose SC et al (2010) Practice guideline for adult antibiotic prophylaxis during vascular and interventional radiology procedures. J Vasc Interv Radiol 21(11):1611\u20131630","journal-title":"J Vasc Interv Radiol"},{"issue":"09","key":"7106_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1055\/a-0659-9864","volume":"50","author":"J-M Dumonceau","year":"2018","unstructured":"Dumonceau J-M, Tringali A, Papanikolaou I, Blero D, Mangiavillano B, Schmidt A et al (2018) Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline \u2013 Updated October 2017. Endoscopy 50(09):910\u2013930","journal-title":"Endoscopy"},{"issue":"5","key":"7106_CR42","doi-asserted-by":"publisher","first-page":"e0155479","DOI":"10.1371\/journal.pone.0155479","volume":"11","author":"C L\u00fcbbert","year":"2016","unstructured":"L\u00fcbbert C, Wendt K, Feisthammel J, Moter A, Lippmann N, Busch T et al (2016) Epidemiology and resistance patterns of bacterial and fungal colonization of biliary plastic stents: a prospective cohort study. Alpini GD, editor. PLoS One 11(5):e0155479","journal-title":"PLoS One"},{"issue":"10","key":"7106_CR43","doi-asserted-by":"publisher","first-page":"e110112","DOI":"10.1371\/journal.pone.0110112","volume":"9","author":"J Schneider","year":"2014","unstructured":"Schneider J, Hapfelmeier A, Fremd J, Schenk P, Obermeier A, Burgkart R et al (2014) Biliary endoprosthesis: a prospective analysis of bacterial colonization and risk factors for sludge formation. Schuch R, editor. PLoS One 9(10):e110112","journal-title":"PLoS One"},{"issue":"3","key":"7106_CR44","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4103\/jcrt.JCRT_1705_20","volume":"17","author":"C Wang","year":"2021","unstructured":"Wang C, Yu H, He J, Li M, Zhang L, Xu Y et al (2021) Comparative analysis of bile culture and blood culture in patients with malignant biliary obstruction complicated with biliary infection. J Can Res Ther 17(3):726","journal-title":"J Can Res Ther"},{"issue":"5","key":"7106_CR45","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00270-011-0263-2","volume":"35","author":"H Yu","year":"2012","unstructured":"Yu H, Guo Z, Xing W, Guo X, Liu F, Li B (2012) Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol 35(5):1136\u20131144","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"7106_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","volume":"50","author":"M Ulldemolins","year":"2011","unstructured":"Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50(2):99\u2013110","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"7106_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/11595650-000000000-00000","volume":"51","author":"FM Musteata","year":"2012","unstructured":"Musteata FM (2012) Calculation of normalized drug concentrations in the presence of altered plasma protein binding. Clin Pharmacokinet 51(1):55\u201368","journal-title":"Clin Pharmacokinet"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07106-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07106-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07106-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:11:08Z","timestamp":1655788268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07106-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7106"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07106-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Data Protection Authority (Commission Nationale Informatique et Libert\u00e9s), which is responsible for the protection of individual data in France, approved the study. The protocol was registered as CHU86-R2019-10-03.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Since French law does not require written informed consent for retrospective studies, all individual participants alive at the time of the study were informed of the study and were asked for their permission to collect and utilize their individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Blandine Rammaert received speaker\u2019s fees from Gilead, Merck, Astellas, and IQone, and travel grant for conferences from Gilead, Pfizer, and Merck. Maxime Pichon received speaker\u2019s fees from Pfizer. All other authors declared having no conflict of interest directly linked to this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}